Bioline Rx Ltd (BLRX)

$0.83

+0.04

(+5.08%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $0.78
    $0.88
    $0.83
    downward going graph

    5.9%

    Downside

    Day's Volatility :11.24%

    Upside

    5.67%

    downward going graph
  • $0.51
    $2.53
    $0.83
    downward going graph

    38.55%

    Downside

    52 Weeks Volatility :79.84%

    Upside

    67.19%

    downward going graph

Returns

PeriodBioline Rx LtdIndex (Russel 2000)
3 Months
22.58%
0.0%
6 Months
-40.29%
0.0%
1 Year
-46.1%
0.0%
3 Years
-74.77%
-19.6%

Highlights

Market Capitalization
68.4M
Book Value
$0.01
Earnings Per Share (EPS)
-0.76
PEG Ratio
0.2
Wall Street Target Price
13.75
Profit Margin
0.0%
Operating Margin TTM
-70.34%
Return On Assets TTM
-40.5%
Return On Equity TTM
-188.4%
Revenue TTM
11.7M
Revenue Per Share TTM
0.18
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-37.5M
Diluted Eps TTM
-0.76
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.47
EPS Estimate Next Year
-0.42
EPS Estimate Current Quarter
-0.29
EPS Estimate Next Quarter
-0.15

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 1556.63%

Current $0.83
Target $13.75

Technicals Summary

Sell

Neutral

Buy

Bioline Rx Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bioline Rx Ltd
Bioline Rx Ltd
36.07%
-40.29%
-46.1%
-74.77%
-78.93%
Moderna, Inc.
Moderna, Inc.
-11.58%
21.5%
-1.52%
-62.55%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.03%
12.81%
46.27%
81.23%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-7.55%
24.69%
62.32%
198.21%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.5%
11.69%
37.68%
150.78%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bioline Rx Ltd
Bioline Rx Ltd
NA
NA
0.2
-0.47
-1.88
-0.4
NA
0.01
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bioline Rx Ltd
Bioline Rx Ltd
NA
$68.4M
-78.93%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Bioline Rx Ltd

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.8% return, outperforming this stock by 107.9%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 198.2% return, outperforming this stock by 273.0%

Institutional Holdings

  • Morgan Stanley - Brokerage Accounts

    0.36%
  • Susquehanna International Group, LLP

    0.26%
  • Values First Advisors Inc

    0.25%
  • LPL Financial Corp

    0.13%
  • Atria Wealth Solutions, Inc.

    0.12%
  • Geode Capital Management, LLC

    0.05%

Company Information

biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'​in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m

Organization
Bioline Rx Ltd
Employees
79
CEO
Mr. Philip A. Serlin CPA, M.B.A., CPA, MBA
Industry
Health Technology

FAQs